AnheuserBusch InBev Shares Dip on Revenue Miss Retail Hiring Surges in April But Consumer Caution Flags Potential Slowdown CD Rates Reach 4 APY as of May 27 2026 What Savers Need to Know ASML Holding NV Deepens India Presence Through Tata Electronics Partnership Portugals Meo Sues State for 82 Million Over Huawei 5G Ban New York Bill Proposes Mandatory AI Job Impact Reporting TWOD Q1 2026 Earnings Strong EPS Surprise of 2947 Delivers Beat CVR Partners UAN Q1 2026 Earnings Strong PerUnit Income Amid Steady Fertilizer Demand GPMT Q1 2026 Earnings NarrowerThanExpected Loss Signals Potential Stabilization NetSol Technologies NTWK Q1 2026 Earnings Positive EPS Results Amid Limited Disclosure Community Healthcare Trust Incorporated CHCT Q1 2026 Earnings Massive Earnings Surprise as Profitability Rebounds Sharply Sunstone Hotel Investors Inc SHO Q1 2026 Earnings EPS Surges Past Estimates Despite Flat Revenue Disclosure FG Merger II Corp FGMC Holds Near 1033 as SPAC Awaits Merger Catalyst Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness Loar Holdings LOAR Edges Lower Amid Consolidation Key Levels to Watch First Internet Bancorp INBK Retreats Slightly as Stock Tests Nearby Support Levels Sidus Space SIDU Surges 24 Breaking Above Key Resistance Levels Regulatory Storm Brews 16 States Take Legal Action Against Prediction Markets OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance MasterBrand Inc MBC Surges Over 7 Resistance and Support in Focus INTC Q1 2026 Earnings Major EPS Beat Amid Mixed Signals AMBA Q1 2026 Earnings EPS Surpasses Estimates by 2428 as Edge AI Demand Drives Profitability MSCI Inc MSCI Q1 2026 Earnings Narrow EPS Beat Reflects Stability in Index Analytics Westwater Resources Inc WWR Q1 2026 Earnings Modest EPS Beat as PreRevenue Graphite Developer Advances SAFE Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher CLDX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline